GSK-3β is particularly important in tumor progression and modulation of oncogenes (including beta-catenin, cyclin D1, and c-Myc) because it acts as a part of the destruction complex of β-catenin in the Wnt/β-catenin pathway. Here, GSK3B is linked to neoplasm.